197 related articles for article (PubMed ID: 21326611)
21. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
22. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
23. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia.
Real PJ; Tosello V; Palomero T; Castillo M; Hernando E; de Stanchina E; Sulis ML; Barnes K; Sawai C; Homminga I; Meijerink J; Aifantis I; Basso G; Cordon-Cardo C; Ai W; Ferrando A
Nat Med; 2009 Jan; 15(1):50-8. PubMed ID: 19098907
[TBL] [Abstract][Full Text] [Related]
24. Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis.
Riz I; Hawley TS; Johnston H; Hawley RG
Br J Haematol; 2009 Apr; 145(1):140-3. PubMed ID: 19133982
[No Abstract] [Full Text] [Related]
25. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
[TBL] [Abstract][Full Text] [Related]
26. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
27. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
28. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
[TBL] [Abstract][Full Text] [Related]
29. Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.
Liu H; Chiang MY; Pear WS
Int J Hematol; 2011 Aug; 94(2):118-125. PubMed ID: 21814881
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic targeting of HES1 transcriptional programs in T-ALL.
Schnell SA; Ambesi-Impiombato A; Sanchez-Martin M; Belver L; Xu L; Qin Y; Kageyama R; Ferrando AA
Blood; 2015 Apr; 125(18):2806-14. PubMed ID: 25784680
[TBL] [Abstract][Full Text] [Related]
31. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia.
Medyouf H; Alcalde H; Berthier C; Guillemin MC; dos Santos NR; Janin A; Decaudin D; de Thé H; Ghysdael J
Nat Med; 2007 Jun; 13(6):736-41. PubMed ID: 17515895
[TBL] [Abstract][Full Text] [Related]
32. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
[TBL] [Abstract][Full Text] [Related]
33. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
34. Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model.
Yu P; Petrus MN; Ju W; Zhang M; Conlon KC; Nakagawa M; Maeda M; Bamford RN; Waldmann TA
Leukemia; 2015 Mar; 29(3):556-66. PubMed ID: 25118879
[TBL] [Abstract][Full Text] [Related]
35. Ectopic TLX1 expression accelerates malignancies in mice deficient in DNA-PK.
Krutikov K; Zheng Y; Chesney A; Huang X; Vaags AK; Evdokimova V; Hough MR; Chen E
PLoS One; 2014; 9(2):e89649. PubMed ID: 24586935
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia.
Paganin M; Ferrando A
Blood Rev; 2011 Mar; 25(2):83-90. PubMed ID: 20965628
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors.
Riz I; Lee HJ; Baxter KK; Behnam R; Hawley TS; Hawley RG
Biochem Biophys Res Commun; 2009 Mar; 380(2):361-5. PubMed ID: 19250647
[TBL] [Abstract][Full Text] [Related]
38. Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency.
Blackburn JS; Liu S; Raiser DM; Martinez SA; Feng H; Meeker ND; Gentry J; Neuberg D; Look AT; Ramaswamy S; Bernards A; Trede NS; Langenau DM
Leukemia; 2012 Sep; 26(9):2069-78. PubMed ID: 22538478
[TBL] [Abstract][Full Text] [Related]
39. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia.
Chiang MY; Xu L; Shestova O; Histen G; L'heureux S; Romany C; Childs ME; Gimotty PA; Aster JC; Pear WS
J Clin Invest; 2008 Sep; 118(9):3181-94. PubMed ID: 18677410
[TBL] [Abstract][Full Text] [Related]
40. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
